Intervention Protocol

Pharmaceutical policies: effects on rational drug use

  1. Morten Aaserud1,*,
  2. Astrid Austvoll-Dahlgren2,
  3. Heidrun Sturm3,
  4. Jan Peter Kösters4,
  5. Suzanne Hill5,
  6. Curt Furberg6,
  7. Roberto Grilli7,
  8. David A Henry8,
  9. Andrew D Oxman9,
  10. Craig R Ramsay10,
  11. Dennis Ross-Degnan11,
  12. Stephen B Soumerai12

Editorial Group: Cochrane Effective Practice and Organisation of Care Group

Published Online: 19 APR 2006

DOI: 10.1002/14651858.CD004397.pub2

How to Cite

Aaserud M, Austvoll-Dahlgren A, Sturm H, Kösters JP, Hill S, Furberg C, Grilli R, Henry DA, Oxman AD, Ramsay CR, Ross-Degnan D, Soumerai SB. Pharmaceutical policies: effects on rational drug use (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004397. DOI: 10.1002/14651858.CD004397.pub2.

Author Information

  1. 1

    Norwegian Medicines Agency, Statens legemiddelverk, Oslo, Norway

  2. 2

    Norwegian Knowledge Centre for the Health Services, Oslo, Norway

  3. 3

    University Medical Center Tübingen, Comprehensive Cancer Center, Tübingen, Germany

  4. 4

    Rigshospitalet, 3343, Nordic Cochrane Centre, Copenhagen Ø, Denmark

  5. 5

    Faculty of Medicine & Health Sciences, The University of Newcastle, Department of Clinical Pharmacology, Newcastle, New South Wales, Australia

  6. 6

    Wake Forest University, Public Health Services, Winston-Salem, USA

  7. 7

    Agenzia Sanitaria Regionale, Bologna, Italy

  8. 8

    Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada

  9. 9

    Norwegian Knowledge Centre for the Health Services, Global Health Unit, Oslo, Norway

  10. 10

    University of Aberdeen, Health Services Research Unit, Division of Applied Health Sciences, Aberdeen, UK

  11. 11

    Harvard Medical School, Drug Policy Research Group, Dept. of Population Medicine, Boston, MA, USA

  12. 12

    Harvard Medical School, Department of Ambulatory Care and Prevention, Boston, MA, USA

*Morten Aaserud, Statens legemiddelverk, Norwegian Medicines Agency, Sven Oftedals vei 8, Oslo, NO-0950, Norway.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2006




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effects of pharmaceutical policies on rational drug use.